Explore ›
Finding
Finding
adverse
Among 111,631 men receiving new testosterone prescriptions, only 5.4% had androgen deficiency properly diagnosed by two low morning testosterone levels, 16.5% had no testosterone levels checked, nearly 13% had relative contraindications, and 1.4% had an absolute contraindication of prostate cancer.
| Effect size | Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindication (prostate cancer) |
| Comparator | Guideline-recommended testosterone prescribing practice (requiring two low morning testosterone levels, baseline hematocrit and PSA, and no contraindications) |
| Effect summary | adverse; Only 5.4% had proper diagnosis; 16.5% had no testosterone levels checked; ~13% had relative contraindications; 1.4% had absolute contraindication (prostate cancer) |
| Adverse events | 1.4% prostate cancer (absolute contraindication), ~13% relative contraindications |
Connected entities
Interventions
Outcomes
Populations